Xin Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xin Tian has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Qiuling Shi
School of Public Health, Chongqing Medical University, Chongqing, People’s Republic of China
4 shared publications - Wei Dai
Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications - Xing Wei
Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications - Cheng Lei
Department of Thoracic Surgery, Sichuan Cancer Center, Chengdu, Sichuan, People’s Republic of China
2 shared publications - Hongfan Yu
Department of Pharmacy, The First Affiliated Hospital of Army Medical University, Third Military Medical University, Chongqing, China
2 shared publications - Jia Liao
Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China
2 shared publications
Latest Publications
- 9 January 2026
- Published by Springer Nature in Quality of Life Research
- Vol. 35 (2) , 36
From questionnaires to single items: independent use of a walking measure in patients after thoracic surgery
Purpose Regular and flexible assessments of patients’ physical status remain a significant challenge in clinical care and treatment. Whether measurement items in established Patient-reported outcome (PRO) questionnaires can be used independently to assess physical status remains unclear. This study aimed to evaluate the clinimetric validity of the independent use of a single-item walking measure. Methods Participants were recruited from a prospective cohort of patients undergoing lung surgery. On postoperative days 1 and 2 (POD 1 and 2), the patients’ physical condition was assessed using the Perioperative Symptom Assessment for Lung surgery (PSA-Lung) and the single-item walking measure (SI-walking) derived from these questionnaire. A one-hour washout period separated the assessments. The objective measure of Timed Up and Go Test (TUGT) was performed on POD2. Results Of the 214 patients, 181 and 117 completed PSA-Lung and SI-walking on POD1 and POD2, respectively. The mean SI-walking score was higher than the mean PSA-Lung walking (MI-walking) score (4.44 ± 2.38 vs 3.64 ± 2.66, P < 0.001, Cohen’s d effect size [ES] = 0.26). TUGT was completed by 111 patients with an average time of 15.17 ± 4.01 s. TUGT had a greater correlation with SI-walking (RSI = 0.61, P < 0.001) than with MI-walking (RMI = 0.31, P = 0.001) scores. ES regarding changes in walking function between POD1 and POD2 were higher with SI-walking (5.14 ± 2.37 vs 3.35 ± 1.97, P < 0.001, ES = 0.81) than with MI-walking (4.15 ± 2.77 vs 2.85 ± 2.28, P < 0.001, ES = 0.50). SI-walking (P = 0.002) was better than MI-walking (P = 0.116) in distinguishing hospitalization length. Conclusions The SI-walking scale demonstrates validity for measuring physical status. The independent use of a single-item walking measure from an established PRO questionnaire is valid in patients after thoracic surgery.
- 9 January 2026
- Published by Springer Nature in Quality of Life Research
- Vol. 35 (2) , 36
From questionnaires to single items: independent use of a walking measure in patients after thoracic surgery
Purpose Regular and flexible assessments of patients’ physical status remain a significant challenge in clinical care and treatment. Whether measurement items in established Patient-reported outcome (PRO) questionnaires can be used independently to assess physical status remains unclear. This study aimed to evaluate the clinimetric validity of the independent use of a single-item walking measure. Methods Participants were recruited from a prospective cohort of patients undergoing lung surgery. On postoperative days 1 and 2 (POD 1 and 2), the patients’ physical condition was assessed using the Perioperative Symptom Assessment for Lung surgery (PSA-Lung) and the single-item walking measure (SI-walking) derived from these questionnaire. A one-hour washout period separated the assessments. The objective measure of Timed Up and Go Test (TUGT) was performed on POD2. Results Of the 214 patients, 181 and 117 completed PSA-Lung and SI-walking on POD1 and POD2, respectively. The mean SI-walking score was higher than the mean PSA-Lung walking (MI-walking) score (4.44 ± 2.38 vs 3.64 ± 2.66, P < 0.001, Cohen’s d effect size [ES] = 0.26). TUGT was completed by 111 patients with an average time of 15.17 ± 4.01 s. TUGT had a greater correlation with SI-walking (RSI = 0.61, P < 0.001) than with MI-walking (RMI = 0.31, P = 0.001) scores. ES regarding changes in walking function between POD1 and POD2 were higher with SI-walking (5.14 ± 2.37 vs 3.35 ± 1.97, P < 0.001, ES = 0.81) than with MI-walking (4.15 ± 2.77 vs 2.85 ± 2.28, P < 0.001, ES = 0.50). SI-walking (P = 0.002) was better than MI-walking (P = 0.116) in distinguishing hospitalization length. Conclusions The SI-walking scale demonstrates validity for measuring physical status. The independent use of a single-item walking measure from an established PRO questionnaire is valid in patients after thoracic surgery.
- 3 July 2025
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 20 (S1) , 1-10
Patient-reported walking difficulty predicting the post-discharge overall function in patients with lung cancer undergoing minimally invasive surgery
Background Postoperative mobility of patients with lung cancer is crucial for their physical rehabilitation. This study aimed to identify severe walking difficulty by a threshold and predicting the functional recovery of patients with lung cancer undergoing minimally invasive surgery (MIS). Methods This prospective study enrolled patients with lung cancer who underwent MIS, divided into two cohorts. The 0–10 scale walking difficulty score was assessed regularly during hospitalization and post-discharge. Chi-square and receiver operating characteristic curve analyses guided to define the threshold, with the Timed Up and Go Test on postoperative day 2 as an anchor in cohort 1. Cohort 2 included patients assessed for walking difficulty at discharge. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 was assessed biweekly for 1 month post-discharge. Post-discharge functional status trajectories were compared based on the threshold. Results Based on cohort 1, the threshold for walking difficulty was set to 4. Cohort 2 patients were categorized using the threshold: 71.26% exhibited no or mild, while 28.74% experienced severe walking difficulty upon discharge. Compliance rates for reporting walking difficulty post-discharge consistently exceeded 60%. Walking difficulty severity significantly impacted post-discharge physical function (P < 0.001), emotional function (P = 0.008), role function (P < 0.001), and quality of life (P = 0.033). Conclusions A patient-reported walking difficulty score of ≥ 4 indicates severe walking difficulty. Significant differences in post-discharge functional status were observed among patients with different walking difficulty degrees. Implications for cancer survivors. Continuous rehabilitation care of severe walking difficulty demonstrates significant prognostic value for post-discharge functional recovery. Trial registration. ClinicalTrials.gov Identifier: ChiCTR2000033016.
- 3 July 2025
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 20 (S1) , 1-10
Patient-reported walking difficulty predicting the post-discharge overall function in patients with lung cancer undergoing minimally invasive surgery
Background Postoperative mobility of patients with lung cancer is crucial for their physical rehabilitation. This study aimed to identify severe walking difficulty by a threshold and predicting the functional recovery of patients with lung cancer undergoing minimally invasive surgery (MIS). Methods This prospective study enrolled patients with lung cancer who underwent MIS, divided into two cohorts. The 0–10 scale walking difficulty score was assessed regularly during hospitalization and post-discharge. Chi-square and receiver operating characteristic curve analyses guided to define the threshold, with the Timed Up and Go Test on postoperative day 2 as an anchor in cohort 1. Cohort 2 included patients assessed for walking difficulty at discharge. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 was assessed biweekly for 1 month post-discharge. Post-discharge functional status trajectories were compared based on the threshold. Results Based on cohort 1, the threshold for walking difficulty was set to 4. Cohort 2 patients were categorized using the threshold: 71.26% exhibited no or mild, while 28.74% experienced severe walking difficulty upon discharge. Compliance rates for reporting walking difficulty post-discharge consistently exceeded 60%. Walking difficulty severity significantly impacted post-discharge physical function (P < 0.001), emotional function (P = 0.008), role function (P < 0.001), and quality of life (P = 0.033). Conclusions A patient-reported walking difficulty score of ≥ 4 indicates severe walking difficulty. Significant differences in post-discharge functional status were observed among patients with different walking difficulty degrees. Implications for cancer survivors. Continuous rehabilitation care of severe walking difficulty demonstrates significant prognostic value for post-discharge functional recovery. Trial registration. ClinicalTrials.gov Identifier: ChiCTR2000033016.
- Open Access
- 29 April 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Sex-related differences in postoperative patient-reported outcomes among lung cancer patients: a multicenter cohort study
Studies on sex-related differences in post-lung cancer surgery symptoms are limited. Understanding these differences may provide insights into patient recovery. Therefore, we investigated sex-related differences in these symptoms and their underlying associated factors. We included patients aged ≥ 18 years undergoing surgery for lung cancer from a multicenter cohort study (CN-PRO-Lung 1) that focused on postoperative lung cancer symptoms trajectories. On a daily assessment schedule, we evaluated patients’ symptoms and their impact on functioning from the day before surgery until discharge using the MD Anderson Symptom Inventory–Lung Cancer module. We evaluated sex-related differences in symptom scores over time and identified influencing factors using linear mixed models. Of 372 eligible patients (196 men and 176 women;) symptoms were milder in men than in women for pain (estimate = 0.427, P = 0.021), fatigue (estimate = 1.071, P < 0.001), shortness of breath (estimate = 0.431, P = 0.021), lack of appetite (estimate = 0.728, P < 0.001), dry mouth (estimate = 0.438, P = 0.015), and constipation (estimate = 0.887, P < 0.001) during postoperative hospitalization (median: 7 days). Pain scores decreased over time in both sexes (estimate = -0.440 in men, P < 0.001; -0.510 in women, P < 0.001), while different factors were associated with increased pain in each group. In men, higher American Society of Anesthesiologists (ASA) classification (estimate = 0.430, P = 0.035), advanced pTNM stage (estimate = 0.550, P = 0.007), and having more than one chest drain (estimate = 0.690, P = 0.001) were associated with greater pain. In women, systematic lymph node dissection was associated with increased pain (estimate = 0.700, P = 0.033). Women reported a higher symptom burden than men in the early postoperative period after lung cancer surgery. Key factors associated with worse postoperative pain include higher ASA classification, advanced pTNM stage, and more than one chest tube in men and systematic lymph node dissection in women. NCT03341377
- 29 April 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Open AccessSex-related differences in postoperative patient-reported outcomes among lung cancer patients: a multicenter cohort study
Studies on sex-related differences in post-lung cancer surgery symptoms are limited. Understanding these differences may provide insights into patient recovery. Therefore, we investigated sex-related differences in these symptoms and their underlying associated factors. We included patients aged ≥ 18 years undergoing surgery for lung cancer from a multicenter cohort study (CN-PRO-Lung 1) that focused on postoperative lung cancer symptoms trajectories. On a daily assessment schedule, we evaluated patients’ symptoms and their impact on functioning from the day before surgery until discharge using the MD Anderson Symptom Inventory–Lung Cancer module. We evaluated sex-related differences in symptom scores over time and identified influencing factors using linear mixed models. Of 372 eligible patients (196 men and 176 women;) symptoms were milder in men than in women for pain (estimate = 0.427, P = 0.021), fatigue (estimate = 1.071, P < 0.001), shortness of breath (estimate = 0.431, P = 0.021), lack of appetite (estimate = 0.728, P < 0.001), dry mouth (estimate = 0.438, P = 0.015), and constipation (estimate = 0.887, P < 0.001) during postoperative hospitalization (median: 7 days). Pain scores decreased over time in both sexes (estimate = -0.440 in men, P < 0.001; -0.510 in women, P < 0.001), while different factors were associated with increased pain in each group. In men, higher American Society of Anesthesiologists (ASA) classification (estimate = 0.430, P = 0.035), advanced pTNM stage (estimate = 0.550, P = 0.007), and having more than one chest drain (estimate = 0.690, P = 0.001) were associated with greater pain. In women, systematic lymph node dissection was associated with increased pain (estimate = 0.700, P = 0.033). Women reported a higher symptom burden than men in the early postoperative period after lung cancer surgery. Key factors associated with worse postoperative pain include higher ASA classification, advanced pTNM stage, and more than one chest tube in men and systematic lymph node dissection in women. NCT03341377
- Open Access
- 1 April 2025
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 19, 883-896
Who is Seeking Traditional Chinese Medicine (TCM) for Cancer? Insights from a Large Cohort in a Rehabilitation Clinic
Purpose: Traditional Chinese Medicine (TCM) is widely used in cancer care, yet its utilization features are not well understood. By providing a comprehensive overview of the demographic and clinical characteristics, symptom burden, HRQoL, and TCM constitution of cancer patients seeking TCM treatment, we aim to offer insights into the integration of TCM into cancer care. Patients and Methods: The questionnaire collected data on demographic and clinical characteristics, the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM), the EuroQol-5Dimensions-5Levels (EQ-5D-5L), and the simplified version of the Constitution in Chinese Medicine Questionnaire (CCMQ). A descriptive analysis was conducted to profile the patients’ status and expectations of TCM. Chi-square or Fisher exact tests were employed to compare the distribution of TCM constitutional types across different cancer diagnoses. Results: Among 3047 eligible patients, 2796 (median age 55) completed the questionnaire and were subsequently included in the analysis. The cohort was predominantly female (56.5%), with lung cancer being the most common primary diagnosis (25.2%). Furthermore, 86.7% of the patients presented with a good performance status (ECOG-PS ≤ 1). The main reasons patients sought TCM treatment were to alleviate cancer-related symptoms (59.4%) and enhance immune function (55.4%). The most prevalent symptoms (scored 1– 10 on a 0– 10 scale) were fatigue (81.1%), followed by disturbed sleep (81.0%), and dry mouth (78.2%). The mean and median EQ-5D-5L utility scores were 0.81 and 0.89, respectively. About 83.4% of cancer patients exhibited a deviation in TCM constitution, with Yang-deficiency being particularly common among them. Conclusion: This study highlights the symptom burden, HRQoL, TCM constitution, and characteristics of patients who pursue TCM treatment. It advances our understanding of TCM’s role in cancer rehabilitation by shedding light on target population potential needs of care. The findings provide a foundation for developing evidence-based strategies to enhance TCM application in clinical settings, optimize resource allocation, and improve rehabilitation outcomes for cancer patients.
- 1 April 2025
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 19, 883-896
Open AccessWho is Seeking Traditional Chinese Medicine (TCM) for Cancer? Insights from a Large Cohort in a Rehabilitation Clinic
Purpose: Traditional Chinese Medicine (TCM) is widely used in cancer care, yet its utilization features are not well understood. By providing a comprehensive overview of the demographic and clinical characteristics, symptom burden, HRQoL, and TCM constitution of cancer patients seeking TCM treatment, we aim to offer insights into the integration of TCM into cancer care. Patients and Methods: The questionnaire collected data on demographic and clinical characteristics, the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM), the EuroQol-5Dimensions-5Levels (EQ-5D-5L), and the simplified version of the Constitution in Chinese Medicine Questionnaire (CCMQ). A descriptive analysis was conducted to profile the patients’ status and expectations of TCM. Chi-square or Fisher exact tests were employed to compare the distribution of TCM constitutional types across different cancer diagnoses. Results: Among 3047 eligible patients, 2796 (median age 55) completed the questionnaire and were subsequently included in the analysis. The cohort was predominantly female (56.5%), with lung cancer being the most common primary diagnosis (25.2%). Furthermore, 86.7% of the patients presented with a good performance status (ECOG-PS ≤ 1). The main reasons patients sought TCM treatment were to alleviate cancer-related symptoms (59.4%) and enhance immune function (55.4%). The most prevalent symptoms (scored 1– 10 on a 0– 10 scale) were fatigue (81.1%), followed by disturbed sleep (81.0%), and dry mouth (78.2%). The mean and median EQ-5D-5L utility scores were 0.81 and 0.89, respectively. About 83.4% of cancer patients exhibited a deviation in TCM constitution, with Yang-deficiency being particularly common among them. Conclusion: This study highlights the symptom burden, HRQoL, TCM constitution, and characteristics of patients who pursue TCM treatment. It advances our understanding of TCM’s role in cancer rehabilitation by shedding light on target population potential needs of care. The findings provide a foundation for developing evidence-based strategies to enhance TCM application in clinical settings, optimize resource allocation, and improve rehabilitation outcomes for cancer patients.